NCT01340963

Brief Summary

The study investigated 100 subjects, both genders, with chronic Chagas disease, confirmed by at least two distinct serological tests, and classified according to Los Andes classification in a long term follow-up aiming at identifying the predictive value of the signal-averaged electrocardiogram for cardiac death and ventricular tachycardia. All subjects admitted to the study were submitted to clinical history taking, physical examination, and noninvasive assessment, including blood pressure measurement, resting 12-lead surface electrocardiogram, 24h ambulatory electrocardiogram monitoring, M-Mode/two-dimensional echocardiogram, signal-averaged electrocardiogram in both time and frequency domains. Selected subjects were further submitted to treadmill stress test and coronary angiography to rule out coronary heart disease. Subjects were followed by non-investigational primary care assistance at three to six months scheduled clinical visits on an outpatients basis. Both noninvasive and invasive evaluation during follow-up were requested at discretion of primary evaluation. Adverse outcomes were ascertained by review of medical records and active contact to either study subjects or their relatives.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 1995

Longer than P75 for all trials

Geographic Reach
2 countries

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 1995

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2001

Completed
10.1 years until next milestone

First Submitted

Initial submission to the registry

April 21, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 25, 2011

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

December 10, 2013

Status Verified

December 1, 2013

Enrollment Period

5.8 years

First QC Date

April 21, 2011

Last Update Submit

December 9, 2013

Conditions

Keywords

Chagas heart diseaseventricular tachycardiaatrial fibrillationstrokecardiac deathsignal averaged electrocardiogram

Outcome Measures

Primary Outcomes (1)

  • Cardiac death [Time Frame: up to 10 years ]

    Defined as intractable heart failure, arrhythmic, coronary occlusion, or sudden death. Assessment twice an year by active and direct contact to subjects or relatives and review of medical records.

    up tp 10 years

Secondary Outcomes (4)

  • Ventricular tachycardia

    up to ten years

  • Stroke, either fatal or nonfatal

    up to 10 years

  • Persistent atrial fibrillation

    up to 10 years

  • Cardiac function and dimensions

    up to 10 years

Study Arms (3)

Class I

Structurally normal heart, no bundle branch block

Class II

Mild symptoms, bundle brunch block or hemi-block on resting surface electrocardiogram, normal cardiac silhouette on plain chest X-ray film, left ventricular diastolic dysfunction as relaxation deficit (type I), none or mild global left ventricular systolic dysfunction

Class III

Overtly symptomatic, enlarged cardiac silhouette on plain chest X-ray film, left ventricular diastolic dysfunction, global systolic dysfunction, ventricular tachycardia, atrio-ventricular block (any degree)

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

One hundred clinically stable subjects with at least 10 years of regular outpatients follow-up and positive epidemiological history and serological confirmation of Chagas disease with ate least two immunological tests.

You may qualify if:

  • Clinically stable outpatients with at least 10 years of regular outpatients follow-up and positive epidemiological history and serological confirmation of Chagas disease with ate least two immunological tests

You may not qualify if:

  • Any degree of atrioventricular block or non-sinus rhythm
  • Previous documented acute coronary events (due to documented obstructive epicardial coronary vessels)
  • Chronic obstructive pulmonary disease
  • Rheumatic valvular heart disease
  • Alcohol addiction
  • Thyroid dysfunction
  • Abnormal serum electrolytes and biochemical abnormalities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

University of Texas at Houston

Houston, Texas, 77030, United States

Location

Hospital Universitário Pedro Ernesto

Rio de Janeiro, Rio de Janeiro, 20551-900, Brazil

Location

Universidade Gama Filho

Rio de Janeiro, Rio de Janeiro, 20740-900, Brazil

Location

Instituto Nacional de Cardiologia

Rio de Janeiro, Rio de Janeiro, Brazil

Location

Related Publications (18)

  • Benchimol-Barbosa PR, Nasario-Junior O, Nadal J. The effect of configuration parameters of time-frequency maps in the detection of intra-QRS electrical transients of the signal-averaged electrocardiogram: impact in clinical diagnostic performance. Int J Cardiol. 2010 Nov 5;145(1):59-61. doi: 10.1016/j.ijcard.2009.04.013. Epub 2009 May 9.

    PMID: 19428130BACKGROUND
  • Benchimol-Barbosa PR, Muniz RT. Ventricular late potential duration correlates to the time of onset of electrical transients during ventricular activation in subjects post-acute myocardial infarction. Int J Cardiol. 2008 Sep 26;129(2):285-7. doi: 10.1016/j.ijcard.2007.05.057. Epub 2007 Aug 10.

    PMID: 17692944BACKGROUND
  • Benchimol-Barbosa PR. Trends on acute Chagas' disease transmitted by oral route in Brazil: steady increase in new cases and a concealed residual fluctuation. Int J Cardiol. 2010 Dec 3;145(3):494-6. doi: 10.1016/j.ijcard.2009.08.030. Epub 2009 Sep 16. No abstract available.

    PMID: 19762096BACKGROUND
  • Benchimol-Barbosa PR, Barbosa-Filho J. Mechanical cardiac remodeling and new-onset atrial fibrillation in long-term follow-up of subjects with chronic Chagas' disease. Braz J Med Biol Res. 2009 Mar;42(3):251-62. doi: 10.1590/s0100-879x2009000300006.

  • Benchimol-Barbosa PR. Predictors of mortality in Chagas' disease: the impact of atrial fibrillation and oral transmission on infected population. Int J Cardiol. 2009 Apr 3;133(2):275-7. doi: 10.1016/j.ijcard.2007.11.053. Epub 2008 Jan 15.

  • Benchimol-Barbosa PR. Cardiac remodeling and predictors for cardiac death in long-term follow-up of subjects with chronic Chagas' heart disease: a mathematical model for progression of myocardial damage. Int J Cardiol. 2009 Jan 24;131(3):435-8. doi: 10.1016/j.ijcard.2007.07.151. Epub 2007 Nov 28.

  • Benchimol-Barbosa PR, Barbosa-Filho J. Atrial mechanical remodeling and new onset atrial fibrillation in chronic Chagas' heart disease. Int J Cardiol. 2008 Jul 21;127(3):e113-5. doi: 10.1016/j.ijcard.2007.04.103. Epub 2007 Aug 8.

  • Benchimol-Barbosa PR. Nonlinear mathematical model for predicting long term cardiac remodeling in Chagas' heart disease: introducing the concepts of 'limiting cardiac function' and 'cardiac function deterioration period'. Int J Cardiol. 2010 Nov 19;145(2):219-221. doi: 10.1016/j.ijcard.2009.05.010. Epub 2009 May 27.

  • Benchimol-Barbosa PR, Kantharia BK, Carvalhaes CG. Nonlinear Dynamics in Long-Term Left Ventricular Remodeling in Chagas Heart Disease and Adverse Outcomes: SEARCH-Rio Substudy. Circulation Research. 2012;111:A351

    RESULT
  • Benchimol-Barbosa PR, Tura BR, Barbosa E, Barbosa-Filho J, Kantharia BK. A Novel Risk Score Based on Noninvasive ECG Monitoring Aiming at Predicting Ventricular Tachycardia and Cardiac Death in Chronic Chagas Disease. Circulation. 2010; 122: A19759.

    RESULT
  • Benchimol Barbosa PR. Noninvasive prognostic markers for cardiac death and ventricular arrhythmia in long-term follow-up of subjects with chronic Chagas' disease. Braz J Med Biol Res. 2007 Feb;40(2):167-78.

  • Benchimol-Barbosa PR, Duque GS, Barbosa-Filho J. Long term cardiac remodelling in chronic Chagas' heart disease. Eur Heart J; 2008. 29(suppl 1): 441-441. doi:10.1093/eurheartj/ehn375

    RESULT
  • Benchimol-Barbosa PR, Duque GS, Barbosa EC, Bomfim AS, Dantas-Carletti MS, Barbosa-Filho J. High spectral turbulence in signal-averaged electrocardiogram is an independent predictor for cardiac death in long-term follow-up of subjects with chronic Chagas disease. Eur Heart J; 2009. 30(suppl 1): 697-697. doi:10.1093/eurheartj/ehp415

    RESULT
  • Benchimol-Barbosa PR, Tura BR, Barbosa EC, Barbosa-Filho J, Kantharia BK. A novel risk score for predicting cardiac death in chronic chagas heart disease based on spectral turbulence analysis of the signal-averaged ECG. Eur Heart J; 2010. 31(suppl 1): 163-163. doi:10.1093/eurheartj/ehq287

    RESULT
  • Benchimol-Barbosa PR, Tura BR, Barbosa-Filho J, Kantharia BK. Increasing 24h incidence of isolated PVC is associated with growing complexity and incidence of cardiac tachyarrhythmia in Chagas heart disease. Eur Heart J; 2010. 31(suppl 1): 480-480. doi:10.1093/eurheartj/ehq288

    RESULT
  • Benchimol-Barbosa PR. Clinical characteristics of spontaneous ventricular tachycardia episodes associated with unfavorable prognosis in chronic Chagas disease. Eur Heart J; 2010. 31(suppl 1): 480-480. doi:10.1093/eurheartj/ehq288

    RESULT
  • PR Benchimol-Barbosa. Ventricular tachyarrhythmic events triggers in chronic Chagas disease. Eur Heart J; 2010. 31(suppl 1): 481-481. doi:10.1093/eurheartj/ehq288

    RESULT
  • Benchimol-Barbosa PR, Tura BR, Barbosa EC, Kantharia BK. Utility of a novel risk score for prediction of ventricular tachycardia and cardiac death in chronic Chagas disease - the SEARCH-RIO study. Braz J Med Biol Res. 2013 Nov;46(11):974-984. doi: 10.1590/1414-431X20133141. Epub 2013 Oct 22.

MeSH Terms

Conditions

Chagas CardiomyopathyArrhythmias, CardiacStrokeDeathTachycardia, VentricularAtrial Fibrillation

Condition Hierarchy (Ancestors)

Chagas DiseaseTrypanosomiasisEuglenozoa InfectionsProtozoan InfectionsParasitic DiseasesInfectionsVector Borne DiseasesCardiomyopathiesHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesTachycardiaCardiac Conduction System Disease

Study Officials

  • Paulo R Benchimol-Barbosa, MD, DSc

    Rio de Janeiro State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head Researcher

Study Record Dates

First Submitted

April 21, 2011

First Posted

April 25, 2011

Study Start

June 1, 1995

Primary Completion

March 1, 2001

Study Completion

December 1, 2012

Last Updated

December 10, 2013

Record last verified: 2013-12

Locations